Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models00:57

Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models

165
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
165
Physiological Pharmacokinetic Models: Assumption with Protein Binding01:13

Physiological Pharmacokinetic Models: Assumption with Protein Binding

99
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
99

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Effects of Personalized Feedback About ALDH2*2, Alcohol Use, and Associated Health Risks on Drinking Intention and Consumption: The Role of Self-Efficacy and Perceived Threat.

Alcohol, clinical & experimental research·2026
Same author

Reply to Ko, Null within-twin estimates on education and dementia: cautions for within-family contrasts.

European journal of epidemiology·2025
Same author

Is educational attainment protective against developing dementia? A twin study of genetic and environmental contributions.

European journal of epidemiology·2025
Same author

Genetic and environmental influences on alcohol consumption in middle to late life.

Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors·2025
Same author

REAL-TIME RECURSIVE ESTIMATION OF, AND UNCERTAINTY QUANTIFICATION FOR, BREATH ALCOHOL CONCENTRATION VIA LQ TRACKING CONTROL-BASED INVERSE FILTERING OF TRANSDERMAL ALCOHOL BIOSENSOR SIGNALS.

Applied mathematics for modern challenges·2024
Same author

A population model-based linear-quadratic Gaussian compensator for the control of intravenously infused alcohol studies and withdrawal symptom prophylaxis using transdermal sensing.

Optimal control applications & methods·2024

Related Experiment Video

Updated: Oct 6, 2025

Disruption of Frontal Lobe Neural Synchrony During Cognitive Control by Alcohol Intoxication
09:26

Disruption of Frontal Lobe Neural Synchrony During Cognitive Control by Alcohol Intoxication

Published on: February 6, 2019

19.0K

Uncertainty Quantification in Estimating Blood Alcohol Concentration From Transdermal Alcohol Level With

Clemens Oszkinat, Susan E Luczak, I G Rosen

    IEEE Transactions on Neural Networks and Learning Systems
    |January 17, 2022
    PubMed
    Summary

    This study introduces a novel method using physics-informed neural networks (PINNs) to estimate blood alcohol levels from transdermal alcohol signals. The approach provides accurate estimations with quantifiable uncertainty, advancing non-invasive alcohol monitoring.

    More Related Videos

    Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
    05:12

    Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

    Published on: June 23, 2023

    1.1K
    Quantification of Ethanol Levels in Zebrafish Embryos Using Head Space Gas Chromatography
    08:22

    Quantification of Ethanol Levels in Zebrafish Embryos Using Head Space Gas Chromatography

    Published on: February 11, 2020

    5.8K

    Related Experiment Videos

    Last Updated: Oct 6, 2025

    Disruption of Frontal Lobe Neural Synchrony During Cognitive Control by Alcohol Intoxication
    09:26

    Disruption of Frontal Lobe Neural Synchrony During Cognitive Control by Alcohol Intoxication

    Published on: February 6, 2019

    19.0K
    Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
    05:12

    Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

    Published on: June 23, 2023

    1.1K
    Quantification of Ethanol Levels in Zebrafish Embryos Using Head Space Gas Chromatography
    08:22

    Quantification of Ethanol Levels in Zebrafish Embryos Using Head Space Gas Chromatography

    Published on: February 11, 2020

    5.8K

    Area of Science:

    • Biomedical Engineering
    • Machine Learning
    • Pharmacokinetics

    Background:

    • Transdermal alcohol sensors offer a non-invasive method for monitoring alcohol consumption.
    • Estimating blood alcohol concentration (BAC) from transdermal signals is challenging due to complex physiological transport dynamics.
    • Existing methods often lack robust uncertainty quantification.

    Purpose of the Study:

    • To develop a physics-informed neural network (PINN) framework for accurate blood alcohol signal estimation from transdermal alcohol signals.
    • To incorporate uncertainty quantification into the estimation process.
    • To validate the proposed method using real-world drinking episode data.

    Main Methods:

    • Utilized a generative adversarial network (GAN) with a residual-augmented loss function to model transdermal alcohol transport and estimate parameter distributions.
    • Developed a secondary PINN for deconvolution to derive the blood alcohol signal from the transdermal signal.
    • Employed a posterior latent variable to refine uncertainty estimates (error bands).

    Main Results:

    • The PINN-based approach successfully estimated blood alcohol signals from transdermal data.
    • The method provided conservative error bands for uncertainty quantification.
    • Sharpening of error bands was achieved using a posterior latent variable.
    • Demonstrated advantages and limitations through application to an extensive dataset.

    Conclusions:

    • Physics-informed neural networks offer a powerful tool for estimating blood alcohol signals from transdermal data.
    • The developed method provides reliable BAC estimation with crucial uncertainty quantification.
    • This approach shows promise for improved non-invasive alcohol monitoring applications.